drugset / Trial / NCT02006290
Efficacy, Safety And Tolerability Study In Subjects With Parkinson's Disease
RandomizedCrossoverDouble-blindBasic science
Summary
The B7441003 study will assess PF-06412562 for motor benefit in Parkinson's disease subjects. Safety, tolerability and PK of PF-06412562 in Parkinson's disease subjects will also be evaluated.
Timeline
- Start
- 2014-03
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06412562 | Unknown | 50 mg | Oral |